Monte Rosa Therapeutics
GLUE
GLUE
52 hedge funds and large institutions have $560M invested in Monte Rosa Therapeutics in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 7 reducing their positions, and 11 closing their positions.
Holders
52
Holders Change
-1
Holders Change %
-1.89%
% of All Funds
0.82%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
10
Increased
25
Reduced
7
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$42.1M |
2 |
2
T. Rowe Price Associates
Baltimore,
Maryland
|
$75M |
3 |
3
BlackRock
New York
|
$43.9M |
4 |
4
State Street
Boston,
Massachusetts
|
$5.18M |
5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$5.01M |